Inadequate intake of vitamin B6 has been associated with cancer risk [16], [57]–[59] and recent studies have shown that a high expression level of PDXK has a positive impact on survival of non-small cell lung cancer (NSCLC) patients [60]. The gene discussed is PDXK; the disease is cancer.